About Bioton S.A.

Company Description

BIOTON is an innovative Polish biotechnology company, which provides patients with safe and complete solutions for diabetes care. Bioton is an unquestionable leader on the Polish market, and in the world’s top eight commercial manufacturers of recombinant human insulin.

Bioton continuously invests in the development of Polish biotechnology. We are the first and only company in Poland which is able to fully translate its technology into commercial use.

Recombinant human insulin is an efficient and safe therapy for most people suffering from diabetes. We strive to become the provider of complete diabetes care solutions and the preferred choice for patients, doctors and the diabetes community.

Year founded

1989

Served area

Worldwide

Headquarters

Starościńska 5, 02-516 Warszawa – Poland

Filings & Publications

2021

Report Q1 H1 Q3 FY
Consolidated Report pl
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

2020

Report Q1 H1 Q3 FY
Consolidated Report pl
Corporate Governance Report
Company Presentation
General Presentation
Sustainability Report
Remuneration Report

Insider Trades

Sign up and we will inform you!

Shareholder information

Shares outstanding

85,864,200

IPO

March 1, 2005

Stock exchange(s)

Warsaw Stock Exchange

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.